Over gewicht en de genen

De afgelopen decennia is het percentage mensen met overgewicht gestaag gegroeid. Tot niet zo lang geleden was het de algemene wijsheid dat elk pondje door het mondje ging. Daar is met het stijgen van de kennis meer nuance in gekomen. Het wordt steeds meer geaccepteerd dat het ontstaan van overgewicht complexer is dan gedacht. Het blijkt een samenspel van genetische, metabole, inflammatoire en omgevingsfactoren te zijn die per individu anders kunnen uitpakken.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Eveline van der Wel

Trefwoorden:

Verschenen in

Referenties

  1. Qi X, Zhang B, Zhao Y, et al. Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression. Endocrinology. 2017 May 1;158(5):1181-1193. doi: 10.1210/en.2017-00039.

  2. Menezo Y, Clement P, Elder K. Are UMFA (un-metabolized folic acid) and endocrine disruptor chemicals (EDCs) co-responsible for sperm degradation? An epigenetic/methylation perspective. Andrologia. 2022 Jul;54(6):e14400. doi: 10.1111/and.14400.

  3. Cresci GA, Bawden E. Gut Microbiome: What We Do and Don't Know. Nutr Clin Pract. 2015 Dec;30(6):734-46. doi: 10.1177/0884533615609899.

  4. Becattini S, Sorbara MT et al. Rapid transcriptional and metabolic adaptation of intestinal microbes to host immune activation. Cell Host Microbe. 2021 Mar 10;29(3):378-393.e5. doi: 10.1016/j.chom.2021.01.003.

  5. Martel J, Chang SH et al. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022 Apr;33(4):247-265. doi: 10.1016/j.tem.2022.01.002.

  6. Scheithauer TPM, Rampanelli E, et al. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front Immunol. 2020 Oct 16;11:571731. doi: 10.3389/fimmu.2020.571731.

  7. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017 Jan 3;127(1):1-4. doi: 10.1172/JCI92035.

  8. Maculewicz E, Antkowiak B et al. The interactions between interleukin-1 family genes: IL1A, IL1B, IL1RN, and obesity parameters. BMC Genomics. 2022 Feb 9;23(1):112. doi: 10.1186/s12864-021-08258-x.

  9. Koc G, Doran T, Uygur MM, Kirac D. Obesity is associated with IL-6 gene polymorphisms rs1800795 and rs1800796 but not SOCS3 rs4969170. Mol Biol Rep. 2022 Dec 20. doi: 10.1007/s11033-022-08129-y.

  10. Felger JC. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders. Curr Neuropharmacol. 2018;16(5):533-558. doi: 10.2174/1570159X15666171123201142.

  11. Cresci GA, Bawden E. Gut Microbiome: What We Do and Don't Know. Nutr Clin Pract. 2015 Dec;30(6):734-46. doi: 10.1177/0884533615609899.

  12. Martel J, Chang SH et al. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022 Apr;33(4):247-265. doi: 10.1016/j.tem.2022.01.002.

  13. Schæbel LK, Bonefeld-Jørgensen EC et al. The influence of persistent organic pollutants in the traditional Inuit diet on markers of inflammation. PLoS One. 2017 May 19;12(5):e0177781. doi: 10.1371/journal.pone.0177781.

  14. Latini G, Gallo F, Iughetti L. Toxic environment and obesity pandemia: is there a relationship? Ital J Pediatr. 2010 Jan 22;36:8. doi: 10.1186/1824-7288-36-8.

  15. Heindel JJ, Schug TT. The perfect storm for obesity. Obesity (Silver Spring). 2013 Jun;21(6):1079-80. doi: 10.1002/oby.20222.

  16. Goutzourelas N, Orfanou M, Charizanis I et al. GSH levels affect weight loss in individuals with metabolic syndrome and obesity following dietary therapy. Exp Ther Med. 2018 Aug;16(2):635-642. doi: 10.3892/etm.2018.6204.

  17. Jackson E, Shoemaker R, Larian N, Cassis L. Adipose Tissue as a Site of Toxin Accumulation. Compr Physiol. 2017 Sep 12;7(4):1085-1135. doi: 10.1002/cphy.c160038. Erratum in: Compr Physiol. 2018 Jun 18;8(3):1251.

  18. Lambrinoudaki I, Kaparos G et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol. 2008 Sep;159(3):233-41. doi: 10.1530/EJE-07-0848.

  19. Worda C, Sator MO et al. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod. 2003 Feb;18(2):262-6. doi: 10.1093/humrep/deg059.

  20. Almeida M, Soares M et al. Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk. Pharmaceuticals (Basel). 2021 Jan 27;14(2):94. doi: 10.3390/ph14020094.
    Li F, Zhu W, Gonzalez FJ. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther. 2017 Oct;178:18-30. doi: 10.1016/j.pharmthera.2017.03.007.

  21. Williams GP. The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur J Cancer Prev. 2010 Jul;19(4):256-71. doi: 10.1097/cej.0b013e328338f7d2.

  22. Takemura H, Itoh T et al. Selective inhibition of methoxyflavonoids on human CYP1B1 activity. Bioorg Med Chem. 2010 Sep 1;18(17):6310-5. doi: 10.1016/j.bmc.2010.07.020.

  23. Mair KM, Gaw R, MacLean MR. Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension. Pulm Circ. 2020 Sep 18;10(3):2045894020952019. doi: 10.1177/2045894020952023.

  24. https://www.natuurdietisten.nl/oestrogeendominantie/

Gerelateerde artikelen

Ketogeen dieet verlaagt ontsteking vetweefsel
Preventie overgewicht bij kinderen: rol van de ouders
Genen reguleren hartritme en bloeddruk
Evolutionaire verklaring voor obesitas
LEFF voor duurzame gewichtsverandering